soilDBdata
soilDBdata exists so soilDB's tests can run without a NASIS connection.
Comparison · Analytics
medsim vs Rho
A side-by-side editorial comparison of medsim and Rho — release velocity, themes, recent moves, and the top alternatives to consider.
medsim vs Rho: at a glance
What is medsim?
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
What is Rho?
Rho's release machinery is now more rigorous than the product it ships.
Rho is an R IDE in open prerelease, and its public feed is almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. Everything around it is build candidates and acceptance targets, each gated behind an explicit acceptance record that fails closed.
medsim vs Rho: editorial side-by-side
medsim
6.3ANALYTICS
medsim is turning simulation runs into auditable artifacts, not just fast ones.
◆ Current state
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
◆ Where it's heading
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
◆ Prediction
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
Rho
6.3ANALYTICS
Rho's release machinery is now more rigorous than the product it ships.
◆ Current state
Rho is an R IDE in open prerelease, and its public feed is almost entirely release engineering. The one substantive entry, 0.4.0-dev.39, described capability-based model routing across providers and durable project-scoped agent conversations with per-file Apply/Undo. Everything around it is build candidates and acceptance targets, each gated behind an explicit acceptance record that fails closed.
◆ Where it's heading
The project is building an agentic R IDE but publishing like a regulated release process: signed evidence, CONDITIONAL_GO records, checksums bound to exact commits, limitations named out loud rather than buried. dev.41 exists solely to rehearse the native updater across Windows and macOS, which is the last piece of distribution infrastructure between a dev train and something installable by people who won't build from source. Feature work and shipping work are advancing on separate tracks.
◆ Prediction
The updater acceptance target points at a 0.4.0 line that can update itself, so the next entry that matters is either dev.40's real publication or the first build not labelled evaluation-only. Whether Windows signing moves off the SignPath trial certificate is the open question these entries leave unanswered.
Alternatives to medsim and Rho
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either medsim or Rho.
collinear
collinear has broken its API twice to stop making the user pick thresholds.
nert
nert put fourteen TERN datasets behind one dispatcher and called it stable.
scTypeEval
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
medrobust
medrobust made its partial-identification bounds usable by giving them confidence intervals.
probmed
probmed went from one probabilistic effect size to a family of them in sixteen days.
Recent activity from medsim and Rho
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 7h agomedsimmedsim 0.5.1 — fixed-branch ARIV
- 11h agoRhoRho 0.4.0-dev.41 Native Updater Acceptance Target
- 3d agoRhoAgent conversations and provider-routed models land in Rho ⚡
- 8d agoRhoCross-platform candidate build awaiting acceptance evidence
- 16d agomedsimmedsim 0.5.0 — chunked-run integrity ⚡
- 23d agoRhoWindows installer build stamp for 0.2.0-dev.12
- 1mo agomedsimseed= now honored in sequential fallback paths
- 2mo agomedsimDocs and dependency metadata synced to the 0.2.0 state
- 2mo agomedsimMissing-data mediation: amputation, non-normal DGMs, D4-MBCO ⚡
- 3mo agomedsimv0.1.1 — cleanup release
Frequently asked questions
What is the difference between medsim and Rho?
They serve adjacent needs but don't currently overlap on shipped themes. medsim and Rho are shipping at a similar cadence (velocity 6.3 vs 6.3, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is medsim better than Rho?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim and Rho are shipping at a similar cadence (velocity 6.3 vs 6.3, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to medsim?
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.
What are the best alternatives to Rho?
Top Rho alternatives in Analytics are ranked by recent ship velocity. Browse the "Rho alternatives" section above for the current picks, or visit /alternatives/yulab-smu-rho for the full list with editorial commentary on each.